Stifel Financial’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Sell
11,222
-439
-4% -$14.2K ﹤0.01% 3102
2025
Q4
$405K Sell
11,661
-2,325
-17% -$82.1K ﹤0.01% 2976
2025
Q3
$508K Sell
13,986
-2,844
-17% -$96.6K ﹤0.01% 2806
2025
Q2
$528K Sell
16,830
-60
-0.4% -$1.86K ﹤0.01% 2747
2025
Q1
$501K Buy
16,890
+1,169
+7% +$35.1K ﹤0.01% 2685
2024
Q4
$464K Sell
15,721
-2,530
-14% -$80K ﹤0.01% 2719
2024
Q3
$568K Sell
18,251
-1,202
-6% -$43.7K ﹤0.01% 2602
2024
Q2
$659K Sell
19,453
-190
-1% -$9.69K ﹤0.01% 2438
2024
Q1
$1.28M Buy
19,643
+1,405
+8% +$96.4K ﹤0.01% 2040
2023
Q4
$1.25M Buy
18,238
+3,776
+26% +$196K ﹤0.01% 2002
2023
Q3
$751K Buy
14,462
+4,295
+42% +$254K ﹤0.01% 2246
2023
Q2
$610K Buy
+10,167
New +$580K ﹤0.01% 2400

Other funds holding IMCR

Stifel Financial's IMCR Position: Q1 2026 in Review

Stifel Financial reduced its Immunocore (IMCR) stake by 3.8% in Q1 2026, selling an estimated $14.2K and leaving 11,222 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

Stifel Financial first reported a position in IMCR in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.28M in Q1 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Stifel Financial held 11,222 shares of Immunocore worth $338K as of Q1 2026.
  • Stifel Financial sold 439 Immunocore shares in Q1 2026, an estimated $14.2K.
  • Immunocore made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3102 holding.
  • Stifel Financial first reported a position in Immunocore in Q2 2023 and has held it in 12 quarters since.
  • Stifel Financial's Immunocore position peaked at $1.28M in Q1 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.